The First International Symposium on Pheochromocytoma, held in October 2005, included discussions about developments concerning these rare catecholamine-producing tumors. Recommendations were made ...

Karel Pacak; Graeme Eisenhofer; Håkan Ahlman; Stefan R Bornstein; Anne-Paule Gimenez-Roqueplo; Ashley B Grossman; Noriko Kimura; Massimo Mannelli; Anne Marie McNicol; Arthur S Tischler ...

The panel of experts at the ISP felt strongly that localization of pheochromocytoma or paraganglioma should only be initiated if the clinical evidence for the presence of tumor is reasonably ...

The histologic features of the tumors were described as resembling pheochromocytoma or carotid-body or glomus-jugulare tumor or as paranganglioma, with considerable overlap in descriptions.

The tumor also known as Pheochromocytoma, was succeffully removed by a team led by Dr. Shishir Shetty, Senior ...

Patients with MEN-1 may develop tumors in the pancreas, which then release excess hormones. MEN type 2A can cause medullary thyroid cancer, hyperparathyroidism, and pheochromocytoma. MEN type 2B is a ...

Many thanks for this valuable additional information on screening, regarding the significance of pheochromocytoma in neurofibromatosis. The incidence of these rare tumors stated in the literature ...

Managing labile hypertension should be done by an expert. There are experts in hypertension who know how to manage very ...